Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,

Slides:



Advertisements
Similar presentations
HIV/AIDS The Epidemic in ANE and E&E So what do we do now? Paul De Lay Senior Advisor on HIV/AIDS Office of HIV/AIDS.
Advertisements

How can we tailor the delivery of the TB/HIV package to IDU? David H.-U. Haerry European AIDS Treatment Group (European Community Advisory Board, Policy.
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
HIV/AIDS and Sex Workers: Implications for Policy Carol Jenkins Alternate Visions Bangkok September 15, 2005.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
1 Global AIDS Epidemic The first AIDS case was diagnosed in years later, 20 million people are dead and 37.8 million people (range: 34.6–42.3 million)
Supporting community action on AIDS in developing countries NO voice NO programs: V ulnerable communities in the EECA region Developed in collaboration.
National AIDS Control Programme 1. National AIDS Control Programme (NACP) launched under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999)
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
HIV, Drugs & Prisons Photo by Mr. Alessandro Scotti, UNODC Good Will Ambassador Gino Vumbaca.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Topic 2 The prevalence of HIV/AIDS and its potential impact on individuals, communities and countries Slide 2.1.
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
Injecting Drug Users: A Global Problem Roger Detels, M.D., M.S.
Public Funding of Syringe Exchange in the US: The Challenges of Failures and Successes and the New Heroin Injectors Don Des Jarlais 1, Heidi Bramson 1,
…at what cost ? …at what cost ?. Ten year review:  Law enforcement at the expense of public health and human rights  Major HIV epidemics among IDU 
Ethics of encouraging subjects receive HIV test results Don C. Des Jarlais, PhD Director of Research Baron Edmond de Rothschild Chemical Dependency Institute.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
1 DO COMMUNITY-BASED OUTREACH PROGRAMS REDUCE HIV RISK BEHAVIORS AND HIV INFECTION? Vietnam Ministry of Health and US Centers for Disease Control and Prevention.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
AIDS Epidemic and Control in China Zeng Yi Chinese Foundation for Prevention of STD and AIDS.
Harm Reduction.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.
1 Current status of harm reduction in Asia International AIDS Conference, Toronto, August 2006 Mr Jimmy Dorabjee Macfarlane Burnet Institute, Melbourne,
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Reducing HIV and HCV Transmission among Injecting Drug Users in New York.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
Thailand is located at the Golden Triangle: Population: 65 millions Current Status of Drug Use and HIV in Thailand Apinun Aramrattana, MD, PhD Faculty.
A global perspective on scaling up harm reduction 2 nd National Harm Reduction Conference, Ukraine, March 2007 Dr Jos Perriens, Director Prevention.
1 Measuring the epidemic: 2 nd Generation Surveillance and the Asia Epidemic Model (AEM) USAID SOTA meeting Washington DC Oct. 7, 2002 Stephen Mills Family.
Resource Needs Model Rachel Sanders October 28 th, 2010.
TRACK C RAPPORTEURS REPORT. Prepared by Anne BuvéBelgium Anne BuvéBelgium Sabina Bindra-BarnesIndia Sabina Bindra-BarnesIndia Saidi KapigaTanzania Saidi.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
Targeted Interventions for IDUs – an overview. Targeted Intervention for IDUs - an Overview 2 Background  In Asia, 4.7 million people were infected with.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
National roll-out of database for HIV prevention programmes among civil society organizations in Ukraine Olga Varetska ICF “International HIV/AIDS Alliance.
AIDS Epidemic Update December /06 e. AIDS Epidemic Update December /06 e TOTAL North America Eastern Europe & Central Asia Latin America.
How to improve law enforcement knowledge about HIV and to work with drug users and sex workers: experiences from Kyrgyzstan Aleksandr Zelichenko, Director.
Prevention of HIV infection: How effectively are countries responding to changing epidemics in the Asia Pacific Region? 1.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Prospects for Ending the HIV Epidemic among Persons who Inject Drugs in Haiphong Vietnam Don C Des.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
HIV/AIDS in Eastern Europe Setting the Stage for Prevention HIV/AIDS in Eastern Europe Setting the Stage for Prevention Thomas E. Novotny, MD, MPH April.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
Stellit HIV and associated infections among youth in Russia.
Housing Status and HIV Risk Behaviors Among Homeless and Housed Persons with HIV in the United States The findings and conclusions in this presentation.
Trends in the Prevalence of Hepatitis C and Hepatitis B and HIV in Seattle Injection Drug Users, 18 – 30 years old, Richard Burt, Holly Hagan,
Monitoring of Pharmaceutical Supply in Countries of Eastern Europe, Central Asia and Caucasus Anna Żakowicz European AIDS Treatment Group Presented at.
Current state of HIV and associated infections epidemic among adolescents and youth: LATVIA Anda Karnite, MPH, PHD Riga Stradins University and Baltic.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
HIV Prevention for IDUs in China and Vietnam: The Problem of Inconsistent Policies Theodore M. Hammett, Ph.D. Abt Associates Inc. Don C. Des Jarlais, Ph.D.
ENDING HIV TRANSMISSION ALONG PEOPLE WHO INJECT DRUGS – THE TALE OF TWO CITIES, NEW YORK CITY (USA) AND HAI PHONG (VIETNAM) Risk Factors Study Team: Don.
Needle and syringe exchange and working with injecting drug users
Global epidemiology of injecting drug use
National Institute on Drug Abuse
Key Affected Populations
The HIV Epidemic among People who Inject Drugs
Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.
Collaborative TB/HIV activities in European Region
Presentation transcript:

Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais, Ph.D. Director of Research Baron Edmond de Rothschild Chemical Dependency Institute Beth Israel Medical Center New York

Potential for Very Rapid Spread of HIV among Injecting Drug Users--Incidence of 20% to 50% Per Year New York City Bangkok Eastern Europe, Russia, Newly Independent States Some areas in Asia and South Asia

Effective Prevention--National Institutes of Health Consensus Development Conference Syringe access/exchange, e.g., New York City (Des Jarlais, et al.) Community Outreach, e.g., Chicago (Weibel, et al.) Drug Abuse Treatment (Methadone), e.g. Philadelphia (Metzger, et al.) Reductions of 70% to 83% in rates of new HIV infections

Successful Prevention at the Community and Country Level United Kingdom Australia Many individual cities, e.g., Tacoma, WA

Reversing High Seroprevalence Epidemics among IDUs New York City

Will HIV Prevention Programs for IDUs Work in Developing Transitional Countries?

Sharing/Risky Injection Behaviors of Central and Eastern European Syringe Exchange Participants N=595

Sharing/Risky Injection Behaviors of Russian Syringe Exchange Participants N = 1,076

Current Prevention Programming for IDUs in Eastern Europe and Central Asia, South Asia and East Asia Outreach/Syringe Exchange –184 programs in Eastern Europe, Russia and Central Asia –A few programs in rest of the area Methadone Maintenance –approximately 7000 patients –50% in Slovenia and Croatia –None in Russia and China

Coverage at the Local Level “Criterion” of 60% of local IDU population Probably very few current programs reach this level

Prevention of Sexual Transmission of HIV from Injecting Drug Users to Non-injecting Heterosexual Partners Recent meta-analysis of 33 methodologically rigorous studies (conducted by CDC, Semaan et al. 2002) Some programming is modestly effective compared to no programming Components of effective programming cannot yet be identified Likely issues in adapting/translating to developing countries, e.g., levels of stigmatization and HIV drug use

Possibility that HIV among IDUs Will Lead to Generalized HIV Epidemics Appears to have occurred in Manipur, India Use of commercial sex workers by male IDUs Participation in commercial sex work by female IDUs High prevalence of other STDs facilitating HIV transmission

Issues for Consideration Stigmatization of drug use and HIV-denial of problems Simultaneous epidemics of HIV and injecting drug use Policy support for effective HIV prevention programs Local adaptation Support on the streets-lack of police interference Coverage (60%? at local level) Sustainability